c-Myc tag Peptide: Atomic Benchmarks for Immunoassay Precision

Executive Summary: The c-Myc tag Peptide is a synthetic 10-mer corresponding to human c-Myc residues 410–419, designed for displacement of c-Myc-tagged fusion proteins from anti-c-Myc antibodies in immunoassays (APExBIO). It enables specific inhibition of antibody binding, essential for competitive elution and validation workflows (see related). The c-Myc protein, a well-characterized transcription factor, regulates cell proliferation, apoptosis, and differentiation, and its gene is frequently amplified in cancer (Wu et al. 2021). The peptide is soluble at ≥60.17 mg/mL in DMSO, ≥15.7 mg/mL in water with ultrasonication, but insoluble in ethanol (APExBIO datasheet). Proper storage at -20°C desiccated is essential for maintaining peptide integrity.

Biological Rationale

The c-Myc tag Peptide is derived from the C-terminal sequence (EQKLISEEDL) of the human c-Myc protein, a transcription factor encoded by the MYC proto-oncogene (Wu et al. 2021). c-Myc regulates gene transcription associated with cell cycle progression, growth regulation, apoptosis, and stem cell self-renewal. Dysregulation and amplification of the MYC gene are implicated in numerous cancers, including Burkitt lymphoma and breast cancer. The peptide serves as a functional mimic for the myc tag, enabling experimental manipulation of c-Myc-tagged proteins in biochemical assays (c-Myc tag Peptide: Precision Tool—this article provides updated benchmarks for immunoassay specificity).

Mechanism of Action of c-Myc tag Peptide

In immunoassays, the c-Myc tag Peptide (SKU: A6003) competitively binds to anti-c-Myc monoclonal antibodies, thereby displacing c-Myc-tagged fusion proteins from antibody complexes. This mechanism enables specific elution in affinity purification and validation of antibody binding specificity. The peptide’s sequence (EQKLISEEDL) matches the canonical myc tag, ensuring minimal cross-reactivity and high displacement efficiency. In solution, the peptide’s solubility profile—≥60.17 mg/mL in DMSO and ≥15.7 mg/mL in water (with ultrasonication)—is critical for optimizing assay conditions. Ethanol is not suitable as a solvent due to insolubility (APExBIO product sheet; product page).

Evidence & Benchmarks

• The c-Myc tag Peptide (EQKLISEEDL) enables complete displacement of c-Myc-tagged proteins from anti-c-Myc antibodies in ELISA and immunoprecipitation under standard conditions (pH 7.4, 4°C) (APExBIO).
• c-Myc is a basic helix-loop-helix leucine zipper (bHLH-LZ) transcription factor, regulating genes such as cyclin D1 and ribosomal RNA, and repressing cell cycle inhibitors like p21 (Wu et al. 2021).
• MYC gene amplification correlates with increased tumorigenicity and worse prognosis in human cancers (Wu et al. 2021).
• Peptide solubility in DMSO and water (with sonication) ensures compatibility with most protein biochemistry protocols—solubility ≥60.17 mg/mL in DMSO and ≥15.7 mg/mL in water (APExBIO).
• Stability is maintained for >12 months at -20°C desiccated; reconstituted solutions should be used immediately or stored short-term at -20°C to avoid hydrolysis (APExBIO).

This article extends prior analyses (Unveiling New Frontiers) by providing direct solubility and storage benchmarks under controlled laboratory conditions.

Applications, Limits & Misconceptions

The c-Myc tag Peptide is a validated tool for competitive elution and specificity testing of anti-c-Myc antibodies in immunoprecipitation, ELISA, and western blot workflows. It is also used for displacement of c-Myc-tagged fusion proteins in pull-down assays. In cancer research, it aids in dissecting c-Myc-mediated transcription factor pathways and gene amplification events.

Common Pitfalls or Misconceptions

• The peptide does not inhibit endogenous c-Myc function in living cells; it is a research reagent for in vitro assays only.
• It is not suitable for diagnostic or therapeutic use in humans or animals.
• Peptide is insoluble in ethanol, which can lead to failed assays if used as solvent.
• Long-term storage of peptide solutions at room temperature leads to degradation and reduced activity.
• Excessive peptide concentrations can cause non-specific binding in high-sensitivity assays—optimization is required.

For a broader mechanistic overview, see Advanced Mechanisms and Translational Applications, which details translational applications but does not provide the present article's quantitative solubility and workflow integration data.

Workflow Integration & Parameters

For immunoprecipitation or ELISA, reconstitute the c-Myc tag Peptide in DMSO (≥60.17 mg/mL) or water (≥15.7 mg/mL with ultrasonication). For antibody displacement, incubate at 4°C in phosphate-buffered saline (pH 7.4), typically at 50–200 μg/mL final concentration, for 30–60 minutes. Avoid ethanol as a solvent. Store lyophilized peptide at -20°C, desiccated. Use reconstituted peptide immediately, or aliquot and freeze at -20°C for short-term use. For troubleshooting, refer to APExBIO’s technical support (product page).

This article updates and clarifies Mechanistic Insights and Next-Generation Workflows by specifying recommended solvent systems and stability data under defined laboratory conditions.

Conclusion & Outlook

The c-Myc tag Peptide (A6003, APExBIO) is a validated, highly specific reagent for the competitive displacement of c-Myc-tagged fusion proteins in immunoassays. Its robust solubility, storage stability, and well-defined sequence ensure reproducibility in transcription factor research and cancer biology. While not suitable for therapeutic or diagnostic use, it is indispensable for in vitro studies of c-Myc-driven molecular pathways. Future work may extend peptide applications to novel affinity matrices and multiplexed immunoassays as standards for antibody specificity and displacement kinetics.